What is CRISPR technology and has there been an interest for it in the United States?
In this week’s video, Dr. Brian G.M. Durie discusses gene-editing research taking place that could affect the future of myeloma treatment options.
New lab research in the U.S. is studying the impact of gene editing. It will be very exciting and important in the future.
If you have a question that you’d like to suggest for a future episode of Ask Dr. Durie, please submit it to [email protected].
To reach the IMF InfoLine Coordinators, please call 800.452.2873 or email them at [email protected].
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.